| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Contamination | 2 | 2024 | 7 | 1.920 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2024 | 81 | 1.860 |
Why?
|
| Neuroblastoma | 4 | 2024 | 129 | 1.330 |
Why?
|
| Drosophila melanogaster | 3 | 2018 | 180 | 1.190 |
Why?
|
| Limit of Detection | 2 | 2024 | 59 | 1.170 |
Why?
|
| Methyltransferases | 2 | 2024 | 58 | 1.120 |
Why?
|
| Apoptosis | 8 | 2023 | 1398 | 1.110 |
Why?
|
| RNA, Untranslated | 8 | 2013 | 42 | 1.090 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2021 | 13 | 1.080 |
Why?
|
| RNA | 4 | 2023 | 241 | 1.060 |
Why?
|
| Chromatin | 6 | 2018 | 169 | 1.040 |
Why?
|
| Dimethylamines | 1 | 2024 | 1 | 0.980 |
Why?
|
| Dimethylformamide | 1 | 2024 | 8 | 0.980 |
Why?
|
| o-Phthalaldehyde | 1 | 2024 | 4 | 0.960 |
Why?
|
| Ethylenediamines | 1 | 2024 | 7 | 0.950 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2021 | 35 | 0.950 |
Why?
|
| Metabolic Diseases | 1 | 2023 | 33 | 0.900 |
Why?
|
| Fatty Liver | 1 | 2023 | 64 | 0.880 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 55 | 0.880 |
Why?
|
| Furin | 1 | 2022 | 6 | 0.830 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2022 | 19 | 0.830 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 109 | 0.830 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2022 | 43 | 0.800 |
Why?
|
| Guanine | 1 | 2021 | 45 | 0.770 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 190 | 0.770 |
Why?
|
| DNA Damage | 3 | 2020 | 352 | 0.760 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 262 | 0.750 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 312 | 0.710 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 11 | 0.710 |
Why?
|
| Gamma Rays | 1 | 2019 | 26 | 0.700 |
Why?
|
| Genomic Imprinting | 5 | 2013 | 35 | 0.700 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 179 | 0.700 |
Why?
|
| Humans | 40 | 2024 | 37093 | 0.690 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 60 | 0.680 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2018 | 76 | 0.670 |
Why?
|
| Histones | 6 | 2021 | 190 | 0.660 |
Why?
|
| Drosophila Proteins | 2 | 2018 | 171 | 0.660 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 643 | 0.650 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 10 | 0.630 |
Why?
|
| Epigenesis, Genetic | 5 | 2021 | 219 | 0.620 |
Why?
|
| DNA, Plant | 1 | 2017 | 13 | 0.610 |
Why?
|
| Fibroblasts | 1 | 2019 | 272 | 0.610 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 131 | 0.610 |
Why?
|
| Genome, Plant | 1 | 2017 | 27 | 0.600 |
Why?
|
| Benzoxazoles | 1 | 2017 | 9 | 0.600 |
Why?
|
| Crops, Agricultural | 1 | 2017 | 31 | 0.590 |
Why?
|
| Plants | 1 | 2017 | 99 | 0.560 |
Why?
|
| Triazoles | 1 | 2017 | 86 | 0.560 |
Why?
|
| RNA, Viral | 3 | 2023 | 301 | 0.550 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 1015 | 0.550 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 807 | 0.540 |
Why?
|
| Transcription, Genetic | 5 | 2018 | 578 | 0.520 |
Why?
|
| Plant Roots | 1 | 2017 | 158 | 0.510 |
Why?
|
| MicroRNAs | 2 | 2017 | 426 | 0.490 |
Why?
|
| Animals | 23 | 2021 | 15081 | 0.460 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 935 | 0.450 |
Why?
|
| Linear Models | 2 | 2024 | 275 | 0.450 |
Why?
|
| Cytochrome P-450 CYP2D6 | 2 | 2022 | 17 | 0.430 |
Why?
|
| Cell Line, Tumor | 8 | 2020 | 2231 | 0.400 |
Why?
|
| Hepacivirus | 2 | 2008 | 62 | 0.400 |
Why?
|
| Gene Silencing | 6 | 2013 | 151 | 0.390 |
Why?
|
| Cephalometry | 1 | 2011 | 23 | 0.390 |
Why?
|
| Skull | 1 | 2011 | 35 | 0.380 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2021 | 36 | 0.380 |
Why?
|
| Cell Line | 6 | 2019 | 1354 | 0.370 |
Why?
|
| Face | 1 | 2011 | 51 | 0.370 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 173 | 0.350 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 290 | 0.350 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 626 | 0.340 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2018 | 43 | 0.340 |
Why?
|
| Glycolysis | 2 | 2019 | 68 | 0.330 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 133 | 0.330 |
Why?
|
| Ribonucleoproteins | 1 | 2008 | 29 | 0.330 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 222 | 0.330 |
Why?
|
| Genomics | 2 | 2022 | 223 | 0.320 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1198 | 0.320 |
Why?
|
| Autoantigens | 1 | 2008 | 81 | 0.320 |
Why?
|
| Mice | 15 | 2021 | 5913 | 0.310 |
Why?
|
| Algorithms | 1 | 2011 | 465 | 0.310 |
Why?
|
| Epitopes | 2 | 2023 | 148 | 0.270 |
Why?
|
| RNA, Antisense | 3 | 2011 | 17 | 0.260 |
Why?
|
| Neoplasms | 3 | 2021 | 1103 | 0.260 |
Why?
|
| Staphylococcal Protein A | 2 | 2020 | 2 | 0.250 |
Why?
|
| Benzoates | 1 | 2024 | 16 | 0.240 |
Why?
|
| Adenine | 1 | 2024 | 44 | 0.240 |
Why?
|
| Solvents | 1 | 2024 | 99 | 0.240 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 190 | 0.230 |
Why?
|
| Amino Acid Sequence | 2 | 2022 | 1180 | 0.230 |
Why?
|
| Fas Ligand Protein | 1 | 2023 | 16 | 0.230 |
Why?
|
| Benzamides | 1 | 2024 | 78 | 0.230 |
Why?
|
| Telomere | 1 | 2024 | 56 | 0.230 |
Why?
|
| Antibodies | 1 | 2023 | 141 | 0.220 |
Why?
|
| Immunotherapy | 2 | 2021 | 95 | 0.220 |
Why?
|
| Cricetulus | 2 | 2020 | 80 | 0.220 |
Why?
|
| Methylation | 1 | 2023 | 113 | 0.220 |
Why?
|
| District of Columbia | 1 | 2022 | 71 | 0.220 |
Why?
|
| Slovakia | 1 | 2022 | 7 | 0.210 |
Why?
|
| Dyslipidemias | 1 | 2022 | 43 | 0.210 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2021 | 9 | 0.200 |
Why?
|
| Virus Internalization | 1 | 2022 | 28 | 0.200 |
Why?
|
| Superantigens | 1 | 2001 | 2 | 0.200 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 129 | 0.200 |
Why?
|
| Staphylococcus | 1 | 2001 | 9 | 0.200 |
Why?
|
| Antigens, CD34 | 1 | 2001 | 19 | 0.200 |
Why?
|
| Cell Cycle | 2 | 2019 | 326 | 0.200 |
Why?
|
| Enterotoxins | 1 | 2001 | 33 | 0.200 |
Why?
|
| Immune Evasion | 1 | 2021 | 16 | 0.190 |
Why?
|
| Pilot Projects | 1 | 2023 | 661 | 0.190 |
Why?
|
| rho-Associated Kinases | 1 | 2021 | 31 | 0.190 |
Why?
|
| Female | 12 | 2023 | 20969 | 0.190 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 28 | 0.190 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 357 | 0.190 |
Why?
|
| Antibodies, Bispecific | 1 | 2020 | 3 | 0.190 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 133 | 0.180 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 106 | 0.180 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2018 | 28 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 186 | 0.180 |
Why?
|
| Mitochondria | 3 | 2020 | 487 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 360 | 0.180 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 286 | 0.180 |
Why?
|
| Environmental Exposure | 1 | 2022 | 216 | 0.180 |
Why?
|
| Chromatids | 1 | 2019 | 3 | 0.180 |
Why?
|
| Carbocyanines | 1 | 2019 | 14 | 0.180 |
Why?
|
| Male | 10 | 2021 | 20025 | 0.180 |
Why?
|
| Karyotyping | 1 | 2019 | 47 | 0.180 |
Why?
|
| Aneuploidy | 1 | 2019 | 23 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 75 | 0.180 |
Why?
|
| Chromosomes | 1 | 2019 | 37 | 0.170 |
Why?
|
| Benzimidazoles | 1 | 2019 | 36 | 0.170 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 18 | 0.170 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 84 | 0.170 |
Why?
|
| Aerobiosis | 1 | 2019 | 15 | 0.170 |
Why?
|
| Body Weight | 1 | 2021 | 434 | 0.170 |
Why?
|
| Whole Body Imaging | 1 | 2019 | 25 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 182 | 0.170 |
Why?
|
| Gallbladder Neoplasms | 1 | 2018 | 2 | 0.170 |
Why?
|
| Comet Assay | 1 | 2019 | 76 | 0.170 |
Why?
|
| Mitosis | 1 | 2019 | 99 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2012 | 325 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 213 | 0.160 |
Why?
|
| Contrast Media | 1 | 2019 | 92 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 76 | 0.160 |
Why?
|
| Ubiquitination | 1 | 2018 | 61 | 0.160 |
Why?
|
| Child, Preschool | 2 | 2022 | 1418 | 0.160 |
Why?
|
| Phosphorylation | 2 | 2019 | 928 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 461 | 0.160 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2018 | 31 | 0.160 |
Why?
|
| DNA Repair | 1 | 2019 | 188 | 0.160 |
Why?
|
| Workflow | 1 | 2018 | 20 | 0.160 |
Why?
|
| S Phase | 1 | 2018 | 37 | 0.150 |
Why?
|
| Chromosomes, Plant | 1 | 2017 | 3 | 0.150 |
Why?
|
| Metagenomics | 1 | 2017 | 34 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 251 | 0.150 |
Why?
|
| Organogenesis | 1 | 2017 | 16 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 52 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2017 | 81 | 0.150 |
Why?
|
| Eye | 1 | 2018 | 71 | 0.150 |
Why?
|
| Symbiosis | 1 | 2017 | 43 | 0.150 |
Why?
|
| History, 20th Century | 1 | 2017 | 117 | 0.150 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 188 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2017 | 142 | 0.150 |
Why?
|
| Caspases | 1 | 2017 | 147 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 194 | 0.140 |
Why?
|
| Lung | 1 | 2019 | 446 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 515 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 259 | 0.130 |
Why?
|
| Antioxidants | 1 | 2019 | 416 | 0.130 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2012 | 2 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 37 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2015 | 59 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 358 | 0.130 |
Why?
|
| Child | 2 | 2022 | 3131 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 539 | 0.120 |
Why?
|
| Protein Conformation | 2 | 2021 | 389 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 197 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 239 | 0.120 |
Why?
|
| Models, Biological | 1 | 2017 | 677 | 0.110 |
Why?
|
| Conserved Sequence | 2 | 2010 | 119 | 0.110 |
Why?
|
| United States | 1 | 2022 | 4223 | 0.110 |
Why?
|
| DNA | 1 | 2015 | 574 | 0.100 |
Why?
|
| Cell Nucleolus | 2 | 2008 | 9 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 1609 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2021 | 1908 | 0.100 |
Why?
|
| Radiography | 1 | 2011 | 72 | 0.100 |
Why?
|
| Head | 1 | 2011 | 27 | 0.100 |
Why?
|
| Young Adult | 1 | 2021 | 4268 | 0.100 |
Why?
|
| Cyclopentolate | 1 | 1990 | 1 | 0.090 |
Why?
|
| Postpartum Hemorrhage | 1 | 2010 | 10 | 0.090 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 45 | 0.090 |
Why?
|
| Radiation Dosage | 2 | 2021 | 37 | 0.090 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 10 | 0.090 |
Why?
|
| Mice, SCID | 2 | 2021 | 150 | 0.090 |
Why?
|
| Introns | 1 | 2010 | 75 | 0.090 |
Why?
|
| Brain | 1 | 2018 | 1346 | 0.090 |
Why?
|
| Neuroimmunomodulation | 1 | 2010 | 13 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2011 | 291 | 0.090 |
Why?
|
| Middle Aged | 2 | 2021 | 10129 | 0.090 |
Why?
|
| Cerebellum | 1 | 2010 | 73 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 65 | 0.090 |
Why?
|
| Mammals | 1 | 2010 | 105 | 0.090 |
Why?
|
| Azo Compounds | 1 | 2009 | 20 | 0.080 |
Why?
|
| Palladium | 1 | 2009 | 27 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2010 | 153 | 0.080 |
Why?
|
| India | 3 | 2021 | 88 | 0.080 |
Why?
|
| Ribosomes | 1 | 2008 | 32 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 73 | 0.080 |
Why?
|
| DNA, Catalytic | 1 | 2008 | 2 | 0.080 |
Why?
|
| Adult | 3 | 2021 | 11712 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1568 | 0.080 |
Why?
|
| Imidazoles | 1 | 2009 | 126 | 0.080 |
Why?
|
| Binding Sites | 2 | 2021 | 651 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 74 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 268 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 474 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2010 | 230 | 0.080 |
Why?
|
| Models, Chemical | 1 | 2009 | 207 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 289 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2008 | 157 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2009 | 362 | 0.070 |
Why?
|
| Mutation | 3 | 2021 | 1095 | 0.070 |
Why?
|
| Hippocampus | 1 | 2010 | 561 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2021 | 1518 | 0.070 |
Why?
|
| Aging | 1 | 2010 | 664 | 0.060 |
Why?
|
| Protein Binding | 2 | 2021 | 972 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 517 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1207 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2024 | 59 | 0.060 |
Why?
|
| Pakistan | 1 | 2022 | 20 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2019 | 933 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2022 | 42 | 0.050 |
Why?
|
| Triglycerides | 1 | 2022 | 138 | 0.050 |
Why?
|
| CpG Islands | 2 | 2012 | 97 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2021 | 79 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2001 | 20 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2021 | 77 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 8 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 81 | 0.050 |
Why?
|
| Cholesterol | 1 | 2022 | 205 | 0.050 |
Why?
|
| Karyopherins | 1 | 2020 | 6 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2020 | 30 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2001 | 81 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2001 | 177 | 0.050 |
Why?
|
| Lipids | 1 | 2022 | 235 | 0.050 |
Why?
|
| Spleen | 1 | 2001 | 199 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 59 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 40 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2022 | 353 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2020 | 143 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 185 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 173 | 0.050 |
Why?
|
| CHO Cells | 1 | 2020 | 124 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2001 | 399 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 708 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 207 | 0.040 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hexokinase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Micronucleus Tests | 1 | 2019 | 10 | 0.040 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2019 | 5 | 0.040 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide)-Phosphatase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2019 | 18 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2019 | 59 | 0.040 |
Why?
|
| RNA Polymerase II | 2 | 2009 | 29 | 0.040 |
Why?
|
| Heme | 1 | 2019 | 70 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2020 | 366 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 65 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2019 | 64 | 0.040 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2008 | 12 | 0.040 |
Why?
|
| Plasmodium vivax | 1 | 1998 | 4 | 0.040 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2019 | 95 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 77 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 513 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 243 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 219 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 337 | 0.040 |
Why?
|
| Cytokines | 1 | 2001 | 602 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 431 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 187 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 502 | 0.040 |
Why?
|
| Hela Cells | 1 | 2018 | 366 | 0.040 |
Why?
|
| Time Factors | 2 | 2012 | 1742 | 0.040 |
Why?
|
| Malaria | 1 | 1998 | 78 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 409 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 661 | 0.040 |
Why?
|
| Plasmodium falciparum | 1 | 1998 | 135 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 435 | 0.030 |
Why?
|
| Base Sequence | 2 | 2008 | 997 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 739 | 0.030 |
Why?
|
| Pregnancy | 2 | 2011 | 1549 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 571 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 122 | 0.030 |
Why?
|
| Hospitalization | 1 | 1998 | 388 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 58 | 0.030 |
Why?
|
| Risk | 1 | 2014 | 267 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 48 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2012 | 16 | 0.030 |
Why?
|
| Homozygote | 1 | 2012 | 77 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 601 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2014 | 249 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2011 | 29 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2011 | 87 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2011 | 76 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 153 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 113 | 0.020 |
Why?
|
| Placenta | 1 | 2011 | 97 | 0.020 |
Why?
|
| Administration, Topical | 1 | 1990 | 40 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2011 | 174 | 0.020 |
Why?
|
| Ophthalmic Solutions | 1 | 1990 | 18 | 0.020 |
Why?
|
| Testis | 1 | 2011 | 187 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 173 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2011 | 155 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 767 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 617 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 225 | 0.020 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Thyroxine | 1 | 2010 | 19 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2010 | 41 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 70 | 0.020 |
Why?
|
| Photochemistry | 1 | 2009 | 63 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 321 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 408 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2008 | 13 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 26 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2009 | 167 | 0.020 |
Why?
|
| Enterovirus B, Human | 1 | 2008 | 2 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 265 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 150 | 0.020 |
Why?
|
| Estradiol | 1 | 2010 | 262 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 136 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 146 | 0.020 |
Why?
|
| Plasmids | 1 | 2008 | 246 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2008 | 174 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2010 | 1378 | 0.020 |
Why?
|
| Virus Replication | 1 | 2008 | 278 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 808 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 3562 | 0.010 |
Why?
|
| Quinine | 1 | 1998 | 10 | 0.010 |
Why?
|
| Chloroquine | 1 | 1998 | 19 | 0.010 |
Why?
|
| Malaria, Cerebral | 1 | 1998 | 31 | 0.010 |
Why?
|
| Urban Health | 1 | 1998 | 95 | 0.010 |
Why?
|
| Antimalarials | 1 | 1998 | 55 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1998 | 610 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1998 | 894 | 0.010 |
Why?
|
| Infant | 1 | 1998 | 1046 | 0.010 |
Why?
|